HMC Capital remains unfazed by concerns raised by the Australian Competition and Consumer Commission last month regarding its plan to merge pharmaceutical wholesaler Sigma Healthcare (ASX:SIG) with Chemist Warehouse.

In its monthly fund update, HMC Capital dismissed the ACCC's concerns, noting that the regulator's statement of issues outlined preliminary views on potential competition issues without indicating any definitive red flags.

"The ACCC process aligns with our expectations for a transaction of this nature, and we anticipate a final decision by early September," HMC Capital stated.